Press release
Timmaron Group of Minnesota invests in Open Therapeutics, LLC
Open Therapeutics CEO, Jerome Hamilton says their mission is to help make healthcare affordable and accessible globally. Hamilton says “We are honored to have the Timmaron Group as a member of our investment community, assisting us in making the world a better place.
Barb Stinett CEO & Founder of the Timmaron group says “We are delighted to be a part of the larger Open Therapeutics team. We are impressed with the Open Therapeutics business model and see this as a double bottom line impact which can increase return on our investment while making a positive difference in the scientific research and healthcare space. We have also been very impressed with the Open Therapeutics leadership team and are looking forward to helping Jerome and his team get further acclimated to the Twin Cities business community. For more information about Timmaron Group visit (https://Timmarongroup.com).
About Open Therapeutics LLC
Open Therapeutics (http://OpenTherapeutics.org) is an intellectual property firm that creates and attracts therapeutic technologies and crowdsources them for use by the global scientific community. Researchers can freely access the intellectual properties, funding, lab equipment, manuscript development tool, and preprint server to further the development of the therapeutic technologies (medical devices, pharma, diagnostics) at Therapoid™ (https://Therapoid.net). The Company is headquartered in Cincinnati, OH, with operations Amman, Jordan, and Bangalore, India.
Contact: Jerome Hamilton, CEO, Open Therapeutics
PO Box 30085
Cincinnati, OH 45230
+1.651.900.0412
Jerome@OpenTherapeutics.org
Twitter: @OpenTherapeutic
Telegram: https://t.me/OpenTherapeutics
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Timmaron Group of Minnesota invests in Open Therapeutics, LLC here
News-ID: 1597482 • Views: …
More Releases from Open Therapeutics
Open Therapeutics and American Impact Capital Foundation Form Alliance
American Impact Capital Foundation Provides Non-Fungible Token (NFT) and Cryptocurrency Holders a Route for Philanthropic and Charitable Giving.
Cincinnati, OH and Westport, CT - December 12th, 2022 - Open Therapeutics [ https://OpenTherapeutics.org ], an open science company, announces an alliance with American Impact Capital Foundation [ https://americanimpactcapital.com/ ]. Through this alliance, members of the Open Therapeutics' Therapoid [ https://Therapoid.net/ ] community who wish to donate their NFTs and cryptocurrency assets…
Open Therapeutics is Awarded a Grant from the Blockchain-based Polygon Decentral …
Through this award, Open Therapeutics will accelerate its Web3.0 Polygon blockchain implementation.
Cincinnati, OH, and Polygon DAO - November 8, 2022 - Open Therapeutics (https://OpenTherapeutics.org), an open science company was awarded a grant from the leading blockchain developer organization, the Polygon Decentralized Autonomous Organization (Polygon DAO).
The PolygonDAO is a global blockchain developer community that aims to decentralize, grow, and innovate the Polygon blockchain community. With over 68,000 members in its Official…
Open Therapeutics and IPwe Form an Intellectual Property Partnership.
Through a partnership to enhance the licensing of intellectual properties, the companies will work to jointly encourage the licensing of IP portfolios
Cincinnati, OH, and Paris, France - September 14th, 2022 - Open Therapeutics, an open science company, and IPwe, a global platform leveraging the power of artificial intelligence, predictive analytics, and blockchain technology around smart intangible asset management, announce their collaboration to jointly advance the licensing of intellectual property.
Open Therapeutics'…
